Home

Recent Articles from Benzinga

Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.

Oil Nears A Rough End To 2025, But These Energy ETFs Can Keep Traders In The Gamebenzinga.com
Oil prices are on track to end 2025 with steep losses amid oversupply fears, putting oil and energy-focused ETFs tied to producers, in focus.
Via Benzinga · December 17, 2025
Salesforce Stock Rises On BTIG Buy Rating And Novartis Agentforce Dealbenzinga.com
Salesforce Inc (NYSE:CRM) shares moved higher Wednesday after BTIG kicked off coverage with a Buy rating and a $335 price target, while the company scored a major win with Novartis choosing its Agentforce Life Sciences platform for global customer engagement.
Via Benzinga · December 17, 2025
'That's Dumb. No, I'm Not Doing That'—Dave Ramsey Stuns A Small Business Owner 'Not Making A Profit On A Million Dollars'benzinga.com
Via Benzinga · December 17, 2025
If You Invested $1000 In Lam Research Stock 10 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · December 17, 2025
Bezos‑Backed EV Startup Slate Hits 150,000 Reservations — Can It Capitalize On Ford's Exit?benzinga.com
Slate Auto, an EV pickup truck company backed by Jeff Bezos, has over 150,000 reservations.
Via Benzinga · December 17, 2025
Looking At AbbVie's Recent Unusual Options Activitybenzinga.com
Via Benzinga · December 17, 2025
Smart Money Is Betting Big In SNOW Optionsbenzinga.com
Via Benzinga · December 17, 2025
What Does the Market Think About Perpetua Resources Corp?benzinga.com
Via Benzinga · December 17, 2025
What's Going On With Constellation Energy Stock Wednesday?benzinga.com
The nuclear sector was pressured Wednesday reports hat Blue Owl Capital will not provide funding to build Oracle's next data center.
Via Benzinga · December 17, 2025
AMD Stock Falls Amid China's AI Chip Push And Oracle Funding Concernsbenzinga.com
Advanced Micro Devices shares plunged due to China's semiconductor ambitions and uncertainty around Oracle's data center financing plans.
Via Benzinga · December 17, 2025
JPMorgan Warns: AI Hype Has Peaked — 2026 Is About Profitsbenzinga.com
GenAI fell short of CEO expectations in 2025, with slower monetization and efficiency gains. Investors focus on ROI, not just growth in 2026.
Via Benzinga · December 17, 2025
Here's How Much You Would Have Made Owning Apple Stock In The Last 10 Yearsbenzinga.com
Via Benzinga · December 17, 2025
Bitcoin Slips To $85,000 As Ethereum, XRP, Dogecoin Sink Over 4%benzinga.com
Bitcoin dropped back below $86,000 on Wednesday, erasing the gains from Tuesday.
Via Benzinga · December 17, 2025
What's Driving the Market Sentiment Around Cronos Group Inc?benzinga.com
Via Benzinga · December 17, 2025
Is the Market Bullish or Bearish on Lithium Americas Corp?benzinga.com
Via Benzinga · December 17, 2025
Price Over Earnings Overview: Occidental Petroleumbenzinga.com
Via Benzinga · December 17, 2025
Why Wall Street Cares About Stablecoins More Than Most Crypto Tokensbenzinga.com
Bitcoin gets the headlines. Ethereum powers the smart contracts. Yet behind closed doors on Wall Street, the conversation keeps circling back to something most retail investors barely notice: dollar-pegged stablecoins.
Via Benzinga · December 17, 2025
ChatGPT Thinks CrowdStrike Stock Will Close At This Price In The Next 60 Daysbenzinga.com
Via Benzinga · December 17, 2025
$1000 Invested In Vanguard Growth ETF 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · December 17, 2025
ChatGPT Thinks Palantir Stock Will Close At This Price In The Next 60 Daysbenzinga.com
Via Benzinga · December 17, 2025
Peter Schiff Tells Michael Saylor That Buying Bitcoin While MSTR Trades Below NAV Makes No Sensebenzinga.com
Strategy Inc. (NASDAQ:MSTR) is facing renewed scrutiny after Peter Schiff questioned why the company keeps buying Bitcoin
Via Benzinga · December 17, 2025
ChatGPT Thinks Lucid Stock Will Close At This Price By The End of 2025benzinga.com
Via Benzinga · December 17, 2025
ChatGPT Thinks Rivian Stock Will Close At This Price By The End of 2025benzinga.com
Via Benzinga · December 17, 2025
Smart Money Is Betting Big In CRM Optionsbenzinga.com
Via Benzinga · December 17, 2025
How Do Investors Really Feel About NRG Energy Inc?benzinga.com
Via Benzinga · December 17, 2025
ChatGPT Thinks Broadcom Stock Will Close At This Price By The End of 2025benzinga.com
Via Benzinga · December 17, 2025
ChatGPT Thinks Datadog Stock Will Close At This Price By The End of 2025benzinga.com
Via Benzinga · December 17, 2025
Unity Stock Is Down, But Analysts See Signs Of Strong Performance Aheadbenzinga.com
Unity, Inc. (NYSE:U) shares are trending Wednesday. Wedbush issued positive commentary on the company following an advisor call.
Via Benzinga · December 17, 2025
ChatGPT Thinks AMD Stock Will Close At This Price By The End of 2025benzinga.com
Via Benzinga · December 17, 2025
Alphabet's $100 Billion War Chest Vs. Oracle's Debt Spiral: The AI Arms Race Hits Wall Streetbenzinga.com
Big Tech's AI arms race shifts to balance sheets as Alphabet, Microsoft flex cash power while Meta engineers debt and Oracle faces mounting financial risk.
Via Benzinga · December 17, 2025
Is Momentus Inc Gaining or Losing Market Support?benzinga.com
Via Benzinga · December 17, 2025
Price Over Earnings Overview: Northrop Grummanbenzinga.com
Via Benzinga · December 17, 2025
What's Driving the Market Sentiment Around STMicroelectronics NV?benzinga.com
Via Benzinga · December 17, 2025
XRP, ADA, SOL Slide Drop 3% As Charts Warn That Selloff Isn't Finished Yetbenzinga.com
XRP (CRYPTO: XRP), Cardano
Via Benzinga · December 17, 2025
Tesla Stock Is Pulling Back After All-Time Highs: What's Going On?benzinga.com
Tesla Inc (NASDAQ:TSLA) shares are trading lower on Wednesday, pulling back after hitting all-time highs on Tuesday.
Via Benzinga · December 17, 2025
Broadcom Stock Drops On China AI Chip Threat, Oracle Data Center Funding Setbackbroadcom
Broadcom Inc (NASDAQ:AVGO) shares fell Wednesday as chip stocks came under pressure following reports of a major breakthrough in China's semiconductor ambitions and uncertainty around Oracle's massive data center financing plans.
Via Benzinga · December 17, 2025
Trump Said 'Drill, Baby, Drill': Oil Companies' Answer At $55 Crude, 'We Can't'markets/com
Oil at $55 is below breakeven for many U.S. producers. Here's how Trump's energy push is impacting shale stocks and survival odds.
Via Benzinga · December 17, 2025
From 'Taxation Without Representation To Subscription Without Ownership.' Are We Becoming 'Digital Serfs' For Corporations?benzinga.com
Via Benzinga · December 17, 2025
Unpacking the Latest Options Trading Trends in Meta Platformsbenzinga.com
Via Benzinga · December 17, 2025
How Is The Market Feeling About ARMOUR Residential REIT Inc?benzinga.com
Via Benzinga · December 17, 2025
How Do Investors Really Feel About Innodata Inc?benzinga.com
Via Benzinga · December 17, 2025
CoreWeave Stock Slides As AI Concerns Rise: What's Happening?benzinga.com
CoreWeave, Inc. (NASDAQ:CRWV) is trading lower Wednesday, falling alongside artificial intelligence stocks following reports suggesting that Blue Owl Capital will not provide funding for a $10 billion Oracle data center.
Via Benzinga · December 17, 2025
XRP Slips 9% On The Week, But ETF Inflows Signal Quiet Institutional Accumulationbenzinga.com
XRP (CRYPTO: XRP) has fallen about 9% over the past week, even as steady inflows into spot XRP ETFs point to
Via Benzinga · December 17, 2025
J.B. Hunt Faces Margin Squeeze As Spot Rates Surge: Analystbenzinga.com
JBHT's peak season as expected, cautioned on challenging freight conditions, analyst raised price target and kept buy rating.
Via Benzinga · December 17, 2025
Cigna Offers Cleaner Growth Than Other Health Insurers, Says Analystbenzinga.com
BofA outlines risks and upside for managed care stocks, favoring Cigna and Alignment while flagging Medicare and Medicaid uncertainty.
Via Benzinga · December 17, 2025
Why Is Small Cap Sol-Gel Tech Stock Falling Today?benzinga.com
Sol-Gel Technologies ends development of SGT-210 in Darier disease after Phase 1b data show no efficacy versus vehicle.
Via Benzinga · December 17, 2025
P/E Ratio Insights for FedExbenzinga.com
Via Benzinga · December 17, 2025
10 Financials Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · December 17, 2025
Darden Q2 Preview: Is The 'Unreasonably Cheap' Stock A Value Play?benzinga.com
Darden reported double-digit sales growth in the first fiscal quarter, driven by acquisitions and same-store sales growth.
Via Benzinga · December 17, 2025
What's Going On With Amazon Stock Today?benzinga.com
Shares of Amazon.com, Inc. (NASDAQ: AMZN) are trading higher Wednesday. Reports indicate the company is in talks to invest $10 billion into OpenAI.
Via Benzinga · December 17, 2025
Tesla, Paramount Back In Favor As Conservative Values ETF Rebalancesbenzinga.com
Tesla and Paramount are back in the American Conservative Values ETF as the fund lifts boycotts following a December portfolio rebalance.
Via Benzinga · December 17, 2025
Inflation Report Lands On Thursday: What It Could Mean For Marketsbenzinga.com
November CPI arrives at a critical moment, with markets pricing just 24% odds of a January Fed cut as investors weigh inflation risks.
Via Benzinga · December 17, 2025
Apple Plans 8 New iPhones: Report Says Folding Model, 20th Anniversary Edition In The Worksbenzinga.com
Apple has eight new iPhones in the works that could be released in 2026 and 2027. Here's a look at the phones and how they could help the stock.
Via Benzinga · December 17, 2025
Elizabeth Warren Wants Crypto Investigation, But Coinbase Execs Meet Tim Scott To Negotiate Market Structure Billbenzinga.com
Crypto industry executives and lobbyists met with key U.S. senators on Wednesday for late-stage talks on a stalled market structure bill, as fresh scrutiny from Sen.
Via Benzinga · December 17, 2025
Why Is Inspirato Stock Gaining Today?benzinga.com
Inspirato shares surged after Exclusive Investments agreed to buy the company in an all-cash deal at a premium, taking it private in early 2026.
Via Benzinga · December 17, 2025
Saia Navigates Trucking Turbulence With Clear 2026 Upside, Analyst Saysbenzinga.com
Saia Inc (SAIA) stock fell as investors weighed mixed Q4 freight trends against confidence in long-term national expansion strategy.
Via Benzinga · December 17, 2025
Soligenix Psoriasis Trial Extension Shows Better Outcomes With New Gelbenzinga.com
Soligenix reports positive Phase 2a extension results for SGX302 gel in psoriasis, showing improved skin scores and strong tolerability.
Via Benzinga · December 17, 2025
They Co-Signed A Car Loan As A Couple. After The Breakup, She Kept The Car, Stopped Paying, And Now Plans To Flee With It To Mexicobenzinga.com
Via Benzinga · December 17, 2025
Oracle Delay Sparks Nuclear Stock Selloff: Wall Street Unplugsbenzinga.com
Shares of nuclear power companies sell off as Wall Street digests negative headlines on Oracle and OpenAI's "Stargate" supercomputer project.
Via Benzinga · December 17, 2025
Wealth Makes 'Ugly People Handsome And Pretty,' Says Mark Cuban. 'People Treat You Differently' When You Have Moneybenzinga.com
Via Benzinga · December 17, 2025
What's Going On With Micron Shares Wednesday?benzinga.com
Micron Technology, Inc. (NASDAQ:MU) shares are trading lower Wednesday ahead of first-quarter earnings amid reports that China is working to rival the west in AI chips.
Via Benzinga · December 17, 2025
Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data?benzinga.com
Processa Pharmaceuticals' stock jumps after Phase 2 data show higher capecitabine exposure without added toxicity in metastatic breast cancer patients.
Via Benzinga · December 17, 2025
Recursion Pharmaceuticals Stock Is Soaring Today: Here's Whybenzinga.com
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10.
Via Benzinga · December 17, 2025
Southwest Expands Global Reach With Turkish Airlinesbenzinga.com
Southwest unveils a Turkish Airlines partnership to sell single-ticket U.S.–Istanbul trips starting in early 2026.
Via Benzinga · December 17, 2025
Steel Dynamics Sees Seasonal Pressures Cutting Q4 Steel Profitabilitybenzinga.com
Steel Dynamics projects Q4 EPS $1.65–$1.69, below $2.15 consensus, citing lower steel prices, seasonal demand, and flat-rolled mill outages; strong backlog supports 2026 recovery.
Via Benzinga · December 17, 2025
Decoding Bank of America's Options Activity: What's the Big Picture?benzinga.com
Via Benzinga · December 17, 2025
Peering Into Eaton Corp PLC's Recent Short Interestbenzinga.com
Via Benzinga · December 17, 2025
RXO Faces Margin Pain As Truck Supply Tightens, Analyst Warnsbenzinga.com
RXO facing mounting margin pressure as capacity tightens and spot rates rise, causing forecast cuts and lower expected results.
Via Benzinga · December 17, 2025
5 International ETFs to Buy for 2026benzinga.com
International stocks have outperformed US in 2025, with Spain up 40%, South Korea up 65%. 2026 trend to continue. Top 5 ETFs for 2026: FLKR, EWP.
Via Benzinga · December 17, 2025
Merck's Keytruda-Padcev Combo Boosts Survival In Pivotal Bladder Cancer Trialbenzinga.com
Merck says Keytruda plus Padcev improved survival and response rates versus chemotherapy in a Phase 3 muscle-invasive bladder cancer trial.
Via Benzinga · December 17, 2025
Why Airbnb's Data Is A Hidden Gem In 'The Evolving Consumer AI Landscape'benzinga.com
RBC Capital Markets upgraded Airbnb (NASDAQ: ABNB) to Outperform with a $170 price target, citing strong first-party data and potential for growth in the evolving AI landscape.
Via Benzinga · December 17, 2025
Vistagen's Social Anxiety Disorder Drug Disappoints In Pivotal Late-Stage Studybenzinga.com
Vistagen shares plunge after its Phase 3 fasedienol trial for social anxiety failed to meet the primary endpoint, despite favorable safety data.
Via Benzinga · December 17, 2025
Buying in Gold, Oil, And Dollar On Venezuela Blockade; Silver Hits Record; Fed Credibility At Riskbenzinga.com
Silver Record Please click here for an enlarged chart of Silver Trust
Via Benzinga · December 17, 2025
10 Consumer Discretionary Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · December 17, 2025
10 Information Technology Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · December 17, 2025